Assessing normal bowel function and impact of bowel care medications in children in an intensive care setting

Not Applicable

Completed

• Conditions: Constipation versus non-defecation; Oral and Gastrointestinal - Normal oral and gastrointestinal development and function

• Registration Number: ACTRN12613000810718
• Lead Sponsor: Dr Smalley

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2013-07-24
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

All children admitted to our Intensive Care Unit

Exclusion Criteria

Adults, or being managed by an Adult Specialty team.

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
umber of bowel motion events per day in Intensive Care, counted by the bedside nurse, recording also the consistency of each motion using the Bristol Stool Chart Scale. [Per Day of ICU stay]

Secondary Outcome Measures

Name	Time	Method
Bowel motion effects of protocolised care. This includes altered consistency/number of motions as scored on the Bristol Stool Chart Scale and counted by the bedside nurse, as well as other side effects such as presence of perianal excoriation.[Per bowel motion during hospital stay];Length of Hospital stay[Total Hospital duration until discharge]